The Medical Advisor

Introduction Fenbendazole, a medication traditionally used as an anti-parasitic in veterinary medicine, is gaining unexpected attention for its potential benefits in treating chronic inflammatory and autoimmune conditions such as Multiple Sclerosis (MS), Rheumatoid Arthritis, and Osteoarthritis. While research on its use in humans remains limited and largely under the radar, emerging animal studies and personal testimonials suggest that fenbendazole and ivermectin—may offer significant relief for patients struggling with these debilitating diseases. This post explores the scientific background, shares compelling case reports, and highlights the growing interest in repurposing these medications for conditions far beyond their original scope. Fenbendazole for Multiple Sclerosis Is there any research on the utility of the anti-parasitic Fenbendazole in Multiple Sclerosis? Yes, but it's very well hidden, and you've likely never heard of it. I'll be honest, I hadn...

Fenbendazole for Multiple Sclerosis Is there any research on the utility of the anti-parasitic Fenbendazole in Multiple Sclerosis? Yes, but it's very well hidden, and you've likely never heard of it. I'll be honest, I hadn't either. There is a 2010 paper by Australian Researchers led by A A Ramp: " Strain-related effects of fenbendazole treatment on murine experimental autoimmune encephalomyelitis ". Dr William Makis  posted  on X/Twitter: What is murine experimental autoimmune encephalomyelitis? Animal model of Multiple Sclerosis! "FBZ is delivered orally by premixing into rodent chow at a rate of 150 mg/kg of diet. This assumes an average daily food intake of 8 mg/kg body weight, sufficient to ensure a therapeutic dose". Rodent chow. Sounds delicious. FENBENDAZOLE decreased # of sick mice from 99% to 38.6% in one MS disease model (NOD/LtJ) FENBENDAZOLE decreased # of sick mice from 99% to 62.5% in another MS disease model (C57BL/6J) These ar...

Key Takeaways (2026) Ivermectin  remains an FDA-approved prescription drug for humans  (e.g., parasitic infections like strongyloidiasis and onchocerciasis).  It is  NOT universally over-the-counter (OTC)  in the U.S.—but  state-level laws are rapidly changing . As of 2025–2026,  some states allow pharmacist dispensing or OTC access , while others still require a prescription. ( Wdam ) Availability is  inconsistent by location , even though there is  no nationwide shortage .  Current Legal Status (U.S., 2026) Federal Level Ivermectin tablets are still classified as a  prescription drug for human use  under FDA regulation. ( MedPath ) Doctors may legally prescribe it  off-label  (common practice in U.S. medicine). State-Level Changes (Major 2025–2026 Shift) Several states have passed or proposed laws to expand access: States allowing easier access Idaho  – OTC availability without prescription Arkansas, Tennessee ...